Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions
https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiaa635/5920638?redirectedFrom=fulltext
The Journal of Infectious Diseases - Oxford Academic
Issue Section - Major Article
- Forums
- ASX - By Stock
- Major Article - BIT225, in combination with 3-drug antiretroviral therapy
Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in...
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.002(6.25%) |
Mkt cap ! $28.87M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 3.0¢ | $7.079K | 235.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 143905 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 361155 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 143905 | 0.030 |
6 | 1314507 | 0.029 |
4 | 468000 | 0.028 |
2 | 537000 | 0.027 |
4 | 3124559 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 361155 | 3 |
0.034 | 100000 | 1 |
0.035 | 298251 | 3 |
0.036 | 100000 | 1 |
0.037 | 537816 | 2 |
Last trade - 10.06am 30/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online